These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 17932597
1. Comparison of the effects of two long-acting beta2-agonists on cytokine secretion by human airway epithelial cells. Chiu JC, Hsu JY, Fu LS, Chu JJ, Chi CS. J Microbiol Immunol Infect; 2007 Oct; 40(5):388-94. PubMed ID: 17932597 [Abstract] [Full Text] [Related]
2. Anti-inflammatory activity of beta2-agonists in primary lung epithelial cells is independent of glucocorticoid receptor. Lovén J, Svitacheva N, Jerre A, Miller-Larsson A, Korn SH. Eur Respir J; 2007 Nov; 30(5):848-56. PubMed ID: 17596271 [Abstract] [Full Text] [Related]
3. Effect of formoterol and salmeterol on IL-6 and IL-8 release in airway epithelial cells. Strandberg K, Palmberg L, Larsson K. Respir Med; 2007 Jun; 101(6):1132-9. PubMed ID: 17229563 [Abstract] [Full Text] [Related]
4. Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages. Donnelly LE, Tudhope SJ, Fenwick PS, Barnes PJ. Eur Respir J; 2010 Jul; 36(1):178-86. PubMed ID: 19926732 [Abstract] [Full Text] [Related]
5. Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells. Chu YT, Chang TT, Jong YJ, Kuo PL, Lee HM, Lee MS, Chang HW, Hung CH. Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):345-52. PubMed ID: 20003162 [Abstract] [Full Text] [Related]
6. Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells. Hung CH, Chu YT, Hua YM, Hsu SH, Lin CS, Chang HC, Lee MS, Jong YJ. Eur Respir J; 2008 Jun; 31(6):1313-21. PubMed ID: 18256057 [Abstract] [Full Text] [Related]
7. Anti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts. Descalzi D, Folli C, Nicolini G, Riccio AM, Gamalero C, Scordamaglia F, Canonica GW. Allergy; 2008 Apr; 63(4):432-7. PubMed ID: 18076728 [Abstract] [Full Text] [Related]
8. Long-acting beta 2 agonists suppress IP-10 expression in human bronchial epithelial cells. Chien JW, Chu YT, Yang SN, Kuo CH, Wang WL, Kuo PL, Jong YJ, Hung CH. J Investig Med; 2012 Oct; 60(7):1048-53. PubMed ID: 22914602 [Abstract] [Full Text] [Related]
9. Inhibition by salmeterol and cilomilast of fluticasone-enhanced IP-10 release in airway epithelial cells. Reddy PJ, Aksoy MO, Yang Y, Li XX, Ji R, Kelsen SG. COPD; 2008 Feb; 5(1):5-11. PubMed ID: 18259970 [Abstract] [Full Text] [Related]
10. Inflammatory stimuli inhibit glucocorticoid-dependent transactivation in human pulmonary epithelial cells: rescue by long-acting beta2-adrenoceptor agonists. Rider CF, King EM, Holden NS, Giembycz MA, Newton R. J Pharmacol Exp Ther; 2011 Sep; 338(3):860-9. PubMed ID: 21622733 [Abstract] [Full Text] [Related]
12. Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action. Holden NS, Rider CF, Bell MJ, Velayudhan J, King EM, Kaur M, Salmon M, Giembycz MA, Newton R. Br J Pharmacol; 2010 May; 160(2):410-20. PubMed ID: 20423350 [Abstract] [Full Text] [Related]
13. Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms. Cooper PR, Kurten RC, Zhang J, Nicholls DJ, Dainty IA, Panettieri RA. Br J Pharmacol; 2011 Jun; 163(3):521-32. PubMed ID: 21306583 [Abstract] [Full Text] [Related]
14. Cooperative inhibitory effects of budesonide and formoterol on eosinophil superoxide production stimulated by bronchial epithelial cell conditioned medium. Persdotter S, Lindahl M, Malm-Erjefalt M, von Wachenfeldt K, Korn SH, Stevens T, Miller-Larsson A. Int Arch Allergy Immunol; 2007 Jun; 143(3):201-10. PubMed ID: 17290146 [Abstract] [Full Text] [Related]
15. Corticosteroids plus long-acting β2-agonists prevent double-stranded RNA-induced upregulation of B7-H1 on airway epithelium. Kan-O K, Matsumoto K, Inoue H, Fukuyama S, Asai Y, Watanabe W, Kurokawa M, Araya J, Kuwano K, Nakanishi Y. Int Arch Allergy Immunol; 2013 Jun; 160(1):27-36. PubMed ID: 22948082 [Abstract] [Full Text] [Related]
16. Effect of budesonide and formoterol on IL-6 and IL-8 release from primary bronchial epithelial cells. Strandberg K, Palmberg L, Larsson K. J Asthma; 2008 Apr; 45(3):201-3. PubMed ID: 18415826 [Abstract] [Full Text] [Related]
17. Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses. Ryall JG, Sillence MN, Lynch GS. Br J Pharmacol; 2006 Mar; 147(6):587-95. PubMed ID: 16432501 [Abstract] [Full Text] [Related]
18. Additive anti-inflammatory effects of beta 2 adrenoceptor agonists or glucocorticosteroid with roflumilast in human peripheral blood mononuclear cells. Tannheimer SL, Sorensen EA, Haran AC, Mansfield CN, Wright CD, Salmon M. Pulm Pharmacol Ther; 2012 Apr; 25(2):178-84. PubMed ID: 22306235 [Abstract] [Full Text] [Related]
19. Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells. Korn SH, Jerre A, Brattsand R. Eur Respir J; 2001 Jun; 17(6):1070-7. PubMed ID: 11491146 [Abstract] [Full Text] [Related]
20. Differential control of TH1 versus TH2 cell responses by the combination of low-dose steroids with beta2-adrenergic agonists. Goleva E, Dunlap A, Leung DY. J Allergy Clin Immunol; 2004 Jul; 114(1):183-91. PubMed ID: 15241363 [Abstract] [Full Text] [Related] Page: [Next] [New Search]